(Q47706793)

English

Delta-NT or NT MoM: which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester?

scientific article published in August 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12905507

Delta-NT or NT MoM: which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester? (English)

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12905507

1 reference

based on heuristic

inferred from title

author name string

Spencer K

1

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12905507

Bindra R

2

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12905507

Nix AB

3

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12905507

Heath V

4

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12905507

Nicolaides KH

5

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12905507

publication date

1 August 2003

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12905507

Ultrasound in Obstetrics and Gynecology

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12905507

22

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12905507

2

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12905507

142-148

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12905507

Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy

1 reference

https://api.crossref.org/works/10.1002%2FUOG.186

21 January 2018

The mathematical basis of multivariate risk screening: with special reference to screening for Down's syndrome associated pregnancy.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.186

21 January 2018

One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15 030 pregnancies

1 reference

https://api.crossref.org/works/10.1002%2FUOG.186

21 January 2018

Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience

1 reference

https://api.crossref.org/works/10.1002%2FUOG.186

21 January 2018

Combined ultrasound and biochemical screening for Down's syndrome in the first trimester: a Scottish multicentre study.

1 reference

https://api.crossref.org/works/10.1002%2FUOG.186

21 January 2018

The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome

1 reference

https://api.crossref.org/works/10.1002%2FUOG.186

21 January 2018

Identifiers

10.1002/UOG.186

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12905507

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/12905507

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47706793&oldid=1097696697"